333 related articles for article (PubMed ID: 25687805)
41. Making a case for high-volume robotic surgery centers: A cost-effectiveness analysis of transoral robotic surgery.
Rudmik L; An W; Livingstone D; Matthews W; Seikaly H; Scrimger R; Marshall D
J Surg Oncol; 2015 Aug; 112(2):155-63. PubMed ID: 26171771
[TBL] [Abstract][Full Text] [Related]
42. Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Hobelmann K; Luginbuhl A; Bar-Ad V; Keane W; Curry J; Cognetti D
Laryngoscope; 2017 Sep; 127(9):2050-2056. PubMed ID: 28272799
[TBL] [Abstract][Full Text] [Related]
43. Opioid Usage and Prescribing Predictors Following Transoral Robotic Surgery for Oropharyngeal Cancer.
Abt NB; Holcomb AJ; Feng AL; Suresh K; Mokhtari TE; McHugh CI; Parikh AS; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
Laryngoscope; 2021 Jun; 131(6):E1888-E1894. PubMed ID: 33210756
[TBL] [Abstract][Full Text] [Related]
44. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
Smith RV; Schiff BA; Garg M; Haigentz M
Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
[TBL] [Abstract][Full Text] [Related]
45. Transoral robotic surgery: a 4-year learning experience in a single Danish Cancer Centre.
Isenberg AL; Channir HI; von Buchwald C; Rubek N; Friborg J; Kiss K; Charabi BW
Acta Otolaryngol; 2020 Feb; 140(2):157-162. PubMed ID: 31849248
[No Abstract] [Full Text] [Related]
46. Trans-oral robotic surgery for the management of oropharyngeal carcinomas: a 9-year institutional experience.
Meccariello G; Montevecchi F; D'Agostino G; Iannella G; Calpona S; Parisi E; Costantini M; Cammaroto G; Gobbi R; Firinu E; Sgarzani R; Nestola D; Bellini C; De Vito A; Amadori E; Vicini C
Acta Otorhinolaryngol Ital; 2019 Apr; 39(2):75-83. PubMed ID: 31097824
[TBL] [Abstract][Full Text] [Related]
47. [Transoral robotic surgery for head and neck cancer].
Channir HI; Isenberg AL; Rubek N; Lomholt AF; Scott SI; Tvedskov JF; Charabi BW; Buchwald CV
Ugeskr Laeger; 2018 Nov; 180(47):. PubMed ID: 30509345
[TBL] [Abstract][Full Text] [Related]
48. Transoral Robotic Surgery in the HPV Era.
Duek I; Billan S; Amit M; Gil Z
Rambam Maimonides Med J; 2014 Apr; 5(2):e0010. PubMed ID: 24808948
[TBL] [Abstract][Full Text] [Related]
49. The reconstructive options for oropharyngeal defects in the transoral robotic surgery framework.
Meccariello G; Montevecchi F; Sgarzani R; De Vito A; D'Agostino G; Gobbi R; Bellini C; Vicini C
Oral Oncol; 2017 Mar; 66():108-111. PubMed ID: 28089208
[TBL] [Abstract][Full Text] [Related]
50. Upfront transoral robotic surgery (TORS)
Zorzi SF; Agostini G; Chu F; Tagliabue M; Pietrobon G; Corrao G; Volpe S; Marvaso G; Colombo F; Cossu Rocca M; Gandini S; Gaeta A; Ruju F; Alterio D; Ansarin M
Acta Otorhinolaryngol Ital; 2022 Aug; 42(4):334-347. PubMed ID: 35938555
[TBL] [Abstract][Full Text] [Related]
51. Transoral robotic surgery and human papillomavirus status: Oncologic results.
Cohen MA; Weinstein GS; O'Malley BW; Feldman M; Quon H
Head Neck; 2011 Apr; 33(4):573-80. PubMed ID: 21425382
[TBL] [Abstract][Full Text] [Related]
52. Early T1-T2 stage p16+ oropharyngeal tumours. Role of upfront transoral robotic surgery in de-escalation treatment strategies. A review of the current literature.
Carnevale C; Ortiz-González I; Ortiz-González A; Bodi-Blanes L; Til-Pérez G
Oral Oncol; 2021 Feb; 113():105111. PubMed ID: 33341006
[TBL] [Abstract][Full Text] [Related]
53. Feasibility of robot-assisted neck dissection followed by transoral robotic surgery.
Byeon HK; Holsinger FC; Kim DH; Kim JW; Park JH; Koh YW; Choi EC
Br J Oral Maxillofac Surg; 2015 Jan; 53(1):68-73. PubMed ID: 25453254
[TBL] [Abstract][Full Text] [Related]
54. Robotic vs. transoral laser surgery of malignant oropharyngeal tumors-what is best for the patient? : A contemporary review.
Nagel TH; Chang BA; Hinni ML
HNO; 2022 May; 70(5):371-379. PubMed ID: 35419634
[TBL] [Abstract][Full Text] [Related]
55. Intraoperative imaging during minimally invasive transoral robotic surgery using near-infrared light.
Scott-Wittenborn N; Jackson RS
Am J Otolaryngol; 2018; 39(2):220-222. PubMed ID: 29128262
[TBL] [Abstract][Full Text] [Related]
56. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
Holcomb AJ; Herberg M; Strohl M; Ochoa E; Feng AL; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Sadow P; Faquin W; Faden D; Deschler DG; Varvares MA; Lin DT; Fakhry C; Ryan WR; Richmon JD
Head Neck; 2021 Aug; 43(8):2434-2444. PubMed ID: 33856083
[TBL] [Abstract][Full Text] [Related]
57. Controversies in Postoperative Irradiation of Oropharyngeal Cancer After Transoral Surgery.
Yom SS; Mallen-St Clair J; Ha PK
Surg Oncol Clin N Am; 2017 Jul; 26(3):357-370. PubMed ID: 28576176
[TBL] [Abstract][Full Text] [Related]
58. Transoral surgery (TOS) in oropharyngeal cancer: Different tools, a single mini-invasive philosophy.
Tirelli G; Boscolo Nata F; Piovesana M; Quatela E; Gardenal N; Hayden RE
Surg Oncol; 2018 Dec; 27(4):643-649. PubMed ID: 30449487
[TBL] [Abstract][Full Text] [Related]
59. Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review.
Dowthwaite S; Jackson J; Dzienis M; Khoo E; Cronin M; Guazzo E
Curr Oncol Rep; 2023 May; 25(5):501-510. PubMed ID: 36881215
[TBL] [Abstract][Full Text] [Related]
60. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA
BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
